I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
Stock No. | Größe | Preis ($) | Menge | Verfügbarkeit |
---|---|---|---|---|
H27578-MF | 50mg | 53,90 |
|
|
H27578-MD | 250mg | 155,00 |
|
|
H27578-03 | 1g | 394,00 |
|
|
Used as pharmaceutical intermediate.
Daniela Fattori.; Cristina Rossi.; Christopher I. Fincham.; Valerio Caciagli.; Fernando Catrambone.; Piero D'Andrea.; Patrizia Felicetti.; Martina Gensini.; Elena Marastoni.; Rossano Nannicini.; Marielle Paris.; Rosa Terracciano.; Alessandro Bressan.; Sandro Giuliani.; Carlo A. Maggi.; Stefania Meini .; Claudio Valenti.; Laura Quartara. Design and Synthesis of Novel Sulfonamide-Containing Bradykinin hB2 Receptor Antagonists. 2. Synthesis and Structure-Activity Relationships of α,α-Cycloalkylglycine Sulfonamides.J. Med. Chem. 2007, 50 (3), 550-565 .
Gefahrenhinweise (EU): H315-H319-H335
Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation.
Sicherheitshinweise: P261-P280a-P305+P351+P338-P304+P340-P405-P501a
Avoid breathing dust/fume/gas/mist/vapours/spray. Wear protective gloves and eye/face protection. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.